相关实验视频

Updated: Jun 6, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

通过口服输送的可生物降解的向炎症缓解培涂层的纳米颗粒诱导肠道手术后的无体愈合

Jong Hyun Lee^1,2, Stefan Reischl^3,4, Robert Leon Walter³

¹Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London, UK.

Scientific reports

|November 25, 2024

概括

提供抗炎性的新型纳米颗粒在炎性肠病 (IBD) 的临床前模型中增强了手术伤口愈合. 这种向治疗显示出改善IBD患者接受肠道手术的结果的希望.

科学领域:

胃肠病学胃肠病学
纳米医学是一种纳米医学.
手术创新在外科创新.

背景情况:

在接受肠道手术的炎症性肠病 (IBD) 患者中,解剖疗法至关重要.
手术后的并发症,包括治疗障碍和炎症,是IBD手术中的重大挑战.
目前,在IBD患者中支持动脉直流性愈合的术后治疗选择是有限的.

研究的目的:

在IBD的临床前模型中开发和评估一种基于纳米颗粒 (NP) 的新型药物递送系统,以增强在IBD的前临床模型中进行静脉治疗.
调查Ac2-26载纳米颗粒的向传递和治疗疗效在肠道瘤与大肠炎的小鼠模型中.

主要方法:

开发质涂层的聚合物纳米颗粒,封装着缓解炎症的Ac2-26,设计用于结肠释放和向伤口结合.
使用一种小鼠手术模型,该模型将肠道解与手术前大肠炎诱导相结合.
含有Ac2-26 (P-C-Col IV-Ac2-26-NP) 的氨酸涂层NP的周周手术,以及结肠炎活性,宏观伤口愈合和显微愈合得分的评估.

主要成果:

在外科手术期间使用P-C-Col IV-Ac2-26-NP显著降低了术后结肠炎的活动.
观察到改善的宏观性伤口关闭,由内镜检查和减少腹内粘附证实.
显微镜分析表明,纳米粒子治疗组的半定量愈合得分提高.

结论:

封装Ac2-26的新型素-奇托涂层纳米颗粒代表了一个有希望的有针对性的术后治疗策略.
这种以纳米粒子为基础的方法显示了改善无管愈合和减少炎症性肠病患者手术后并发症的潜力.
开发的药物输送系统为改善IBD手术结果提供了一种临床可行的策略.

关键词:

在ACC2-2626中使用.这是一个解剖学上的解剖学.附录A1 附录 A1 是一个附录.基托桑是一种酸盐.第四类原蛋白原蛋白有控制释放的释放.炎症炎症是一种炎症.炎症性肠病 (IBD) 是一种炎症性肠病.肠道外科手术肠道外科手术纳米医学是一种纳米医学.质素 (Pectin) 是一种可怕的物质.炎症的解消炎症的解消

更多相关视频

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment

Published on: May 31, 2024

相关概念视频

Inflammatory Bowel Disease V: Surgical Management

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...